You are here

CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R44MH108222-02A1
Agency Tracking Number: R44MH108222
Amount: $2,879,146.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: 104
Solicitation Number: PA14-197
Timeline
Solicitation Year: 2014
Award Year: 2018
Award Start Date (Proposal Award Date): 2018-08-01
Award End Date (Contract End Date): 2021-02-28
Small Business Information
3303 SOUTH IRVING ST
Seattle, WA 98144-4012
United States
DUNS: 831785386
HUBZone Owned: No
Woman Owned: Yes
Socially and Economically Disadvantaged: No
Principal Investigator
 LINDA DIMEFF
 (206) 384-7371
 linda@ebpi.org
Business Contact
 KELLY KOERNER
Phone: (206) 265-2507
Email: grants@ebpi.org
Research Institution
N/A
Abstract

PROJECT ABSTRACTOver 44,000 people die annually by suicide in the United States (US) making suicide the 10th leading
cause of death overall and the second leading cause of death among those 10-44. In addition, 9.8 million
adults contemplate suicide annually, and one million will make a suicide attempt. From 2006 to 2013, the rate
of ED visits for suicidal ideation among adults increased by 12% on average annually. While millions are
devoted annually to prevent suicide, suicide rates are rising in the US. Our ultimate aim is to reduce deaths by
suicide while also reducing unnecessary hospitalization, emergency department (ED) and hospital
readmissions, and stop the revolving-door of acute crisis care through the use of innovative technologies.In Phase I, we proposed to: (1) develop and scientifically validate an avatar for use by suicidal ED patients
that delivers the Collaborative Assessment and Management of Suicidality (CAMS), an efficacious and
cost-effective intervention developed by David Jobes, PhD; and (2) to design clinical support tools and Just-in-
Time training for use by ED medical providers to enhance their delivery of an evidence-based suicide protocol
and facilitate an evidence-based approach to discharge disposition. Our work was also guided by Phase I
reviewers’ concerns. We fully met and exceeded project aims. Most notably, we created a 15-minute avatar
(“Dr. Dave”) who performed a portion of the CAMS Suicide Status Interview which was well-liked and
described as helpful by suicidal ED patients who interacted with “Dr. Dave.”In Phase II, we propose to complete the development of Virtual CAMS patient and provider tools and to
ready it for EHR integration into EPIC. We will again use an agile process of development and seek feedback
from target end-users. A diverse group of advisors will consult to us to ensure product excellence and
readiness for commercialization. To ensure thorough testing of the product’s provider and patient tools, we will
use a two-condition, randomized study to evaluate Virtual CAMS’ efficacy in preventing suicidal behaviors and
inappropriate/unnecessary hospital admissions, and improving self-efficacy for coping with acute distress.PROJECT NARRATIVE: PUBLIC HEALTH RELEVANCE
Suicide is the tenth leading cause of death among Americans of all ages and the second leading cause of
death for those 10-44, with 44,965 suicides occurring in the U.S. in 2016 – one suicide every 11.7 minutes.
The Collaborative Assessment and Management of Suicidality (CAMS) is an evidence-based, cost-
effective, suicide-specific intervention that facilitates engagement, assessment, and treatment of suicidal risk.
Virtual CAMS seeks to facilitate the delivery of CAMS and other evidence-based procedures to reduce suicide
during and after the ED visit to reduce suicide.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government